Multiple system atrophy (MSA) is a rare disorder with limited treatment options. However, recent research has yielded encouraging developments into new therapeutic approaches. Current focus centers on modifying the underlying mechanisms of MSA. One strategy under investigation involves pharmacological interventions to modulate the dysregulation of